 |
 |
|
 |
|
Accession |
Disease |
Description |
Year |
Source |
RNA-Seq |
Count |
Biomarkers |
|
GSE109059 |
Ovarian Cancer |
Blocking and randomization to improve molecular biomarker discovery |
2018 |
Tissue |
N |
284 |
 |
|
GSE108838 |
Ovarian Cancer |
A unique pair of microarray datasets for microRNA profiling: data with careful design (Dataset A) |
2018 |
Tissue |
N |
192 |
|
|
GSE109058 |
Ovarian Cancer |
A unique pair of microarray datasets for microRNA profiling: data without careful design (Dataset B) |
2018 |
Tissue |
N |
192 |
|
|
E-MTAB-4667 |
Ovarian Cancer |
microRNA profiling of serum microRNA from high grade serous ovarian carcinoma |
2017 |
Serum |
N |
130 |
|
|
E-MTAB-7084 |
Ovarian Cancer |
microRNA profiling of platinum sensitive and platinum resistant high grade serous ovarian cancer samples |
2018 |
Tissue |
N |
72 |
 |
|
GSE27290 |
Ovarian Cancer |
MicroRNA profiling of advanced serous ovarian carcinoma |
2011 |
Tissue |
N |
62 |
|
|
GSE20592 |
Cervical Cancer |
Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumors and matched controls |
2010 |
Tissue |
Y |
58 |
|
|
GSE25202 |
Ovarian Cancer |
microRNA alterations associated to clinical response in advanced stage ovarian cancer patients (training set) |
2010 |
Tissue |
N |
55 |
|
|
GSE67819 |
Ovarian Cancer |
microRNA alterations associated to early relapse in advanced stage ovarian cancer patients (validation set) |
2015 |
Tissue |
N |
45 |
 |
|
GSE103708 |
Ovarian Cancer |
The profile of exosomal and cellular miRNA in ovarian cancer cell lines |
2017 |
Tissue |
N |
32 |
|
|
GSE25203 |
Ovarian Cancer |
microRNA alterations associated to clinical response in advanced stage ovarian cancer patients (test set) |
2010 |
Tissue |
N |
30 |
|
|
GSE190245 |
Ovarian Cancer |
The profile of microRNA expression and potential role in the regulation of drug-resistant genes in cisplatin and paclitaxel resistant ovarian cancer cell line |
2021 |
Cell line |
N |
15 |
|
|
GSE54665 |
Ovarian Cancer |
miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathway |
2014 |
Cell line |
N |
14 |
|
|
GSE58517 |
Ovarian Cancer |
Detection of urinary microRNAs from epithelial ovarian cancer patients as biomarker |
2014 |
Urine |
N |
10 |
|
|
|
|
|
|
|
|
|